References
- Berns JS (2003): Infection with antimicrobial-resistant microorganisms in dialysis patients. Semin Dialysis 16: 30–37. [CSA]
- Boyce JM (1992): Methicillin-resistant Staphylococcus aureus. in hospitals and long-term care facilities: Microbiology, epidemiology, and preventive measures. Infect Control Hosp Epidemiol 13: 725–737. [PUBMED], [INFOTRIEVE], [CSA]
- Burke B, Nair M (1986): Phenylpropene, benzoic acid and flavonoid derivatives from fruits of Jamaican Piper. species. Phytochemistry 25: 1427–1430. [CSA], [CROSSREF]
- Cardoso CL, Teixeira LM, Gontijo Filho PP (1988): Antimicrobial susceptibilities and phage typing of hospital and non-hospital strains of methicillin-resistant Staphylococcus aureus. isolated from hands. Rev Microbiol 19: 385–392. [CSA]
- Chen CP, LIn CC, Namba T (1989): Screening of Taiwanese crude drugs for antibacterial activity against Streptococcus mutans.. J Ethnopharmacol 27: 285–295. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Farnsworth NR, Bunyapraphatsara N (1992): Thai Medicinal Plants Recommended for Primary Health Care Systems. Bangkok, Prachachon.
- Itokawa H, Morita M, Mihashi S (1981): Phenolic compounds from the rhizomes of Alpinia speciosa.. Phytochemistry 20: 2503–2506. [CSA], [CROSSREF]
- Jagtap AG, Karkera SG (2000): Extract of Juglandaceae regia. inhibits growth, in-vitro. adherence, acid production and aggregation of Streptococcus mutans.. J Pharm Pharmacol 52: 507–551. [CSA], [CROSSREF]
- Järwinen H, Tenovuo J, Huovinen P (1993): In vitro. susceptibility of Streptococcus mutans. to chlorhexidine and six other antimicrobial agents. Antimicrob Agents Chemother 37: 1158–1159. [CSA]
- Kitamura K, Loyola JP, Sobue S (1990): Inhibitory effects of a hot water extract from Japanese tea on the cell growth of mutans streptococci. Shoni Shika gaku Zasshi 28: 618–622. [CSA]
- Koo H, Rosalen PL, Cury JA, Ambrosano GM, Mutara RM, Yatsuda R, Ikegaki M, Alencar SM, Park YK (2000): Effect of a new variety of apis mellifera propolis on mutans streptococci. Curr Microbiol 41: 192–196. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Leclercq R (2002): Gram-positive cocci multiresistant to antibiotics: Activity of linezolid. Med Maladies Infect 32: 449–459. [CSA], [CROSSREF]
- Lorian V (1996): Antibiotics in Laboratory Medicine, 4th ed. Baltimore, Williams & Wilkins.
- Machado TB, Pinto AV, Pinto MCFR, Leal ICR, Silva MG, Amaral ACF, Kuster RM, Netto-dosSantos KR (2003): In vitro. activity of Brazilian medicinal plants, naturally occurring naphthoquinones and their analogues, against methicillin-resistant Staphylococcus aureus.. Inter J Antimicrob Agents 21: 279–284. [CSA], [CROSSREF]
- National Committee for Clinical Laboratory Standards (2000a): Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 5th ed. Approved Standard: M7-A5. Villanova, PA, NCCLS.
- National Committee for Clinical Laboratory Standards (2000b): Performance Standards for Antimicrobial Disc Susceptibility Tests, 7th ed. Approved Standard: M2-A7. Villanova, PA, NCCLS.
- Ramji N, Iyer R, Chandrasekaran S (2002): Phenolic antibacterial from Piper betle. in the prevention of halitosis. J Ethnopharmacol 83: 149–152. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Santos KRN, Teixeira LM, Leal GS, Fonseca LS, Gontijo Filho PP (1999): DNA typing of methicillin-resistant Staphylococcus aureus.: Isolates and factors associated with nosocomial acquisition in two Brazilian university hospitals. J Med Microbiol 48: 17–23. [PUBMED], [INFOTRIEVE], [CSA]
- Tanaka T, Ichino K, Ito K (1985): A novel flavanone, linderatone, from Lindera umbellata.. Chem Pharm Bull 33: 2602–2604. [CSA]
- Taweechaisupapong S, Wongkham S, Chareonsuk S, Suparee S, Srilalai P, Chaiyasak S (2000): Selective activity of Streblus asper. on mutans streptococci. J Ethnopharmacol 70: 73–79. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tewtrakul S, Subhadhirasakul S, Kummee S (2003): HIV-1 protease inhibitory effects of medicinal plants used as self-medication by AIDS patients. Songklanakarin J Sci Technol 25: 239–243. [CSA]
- Tiwawech D, Hirose M, Futakuchi M, Lin C, Thamavit W, Ito N, Shirai T (2000): Enhancing effects of Thai edible plants on 2-amino-3,8-dimethylimidazo (4,5-f. ) quinoxaline-hepatocarcinogenesis in a rat medium-term bioassay. Cancer Lett 158: 195–201. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tuchinda P, Reutrakul V, Claeson P, Pongprayoon U, Sematong T, Santisuk T, Taylor WC (2002): Anti-inflammatory cyclohexenyl chalcone derivatives in Boesenbergia pandurata.. Phytochemistry 59: 169–173. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Venditti M, Baiocchi P, Santini C, Brandimarte C, Serra P, Gentile G, Girmenia C, Martino P (1989): Antimicrobial susceptibilities of Streptococcus. species that cause septicemia in neutropenic patients. Antimicrob Agents Chemother 33: 580–582. [PUBMED], [INFOTRIEVE], [CSA]
- Voravuthikunchai SP, Kitpipit L (2003): Activities of crude extracts of Thai medicinal plants on methicillin-resistant Staphylococcus aureus.. Clin Microbiol Infect 9(Suppl 1): 236. [CSA]
- Voravuthikunchai SP, Lortheeranuwat A, Ninrprom T, Popaya W, Pongpaichit S, Supawita T (2002): Antibacterial activity of Thai medicinal plants against enterohaemorrhagic Escherichia coli. O157: H7. Clin Microbiol Infect 8(Suppl 1): 116–117. [CSA]
- Voravuthikunchai SP, Lortheeranuwat A, Ninrprom T, Popaya W, Pongpaichit S, Supawita T (2004a): Effective medicinal plants against enterohaemorrhagic Escherichia coli. O157:H7. J Ethnopharmacol 94: 49–54. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Voravuthikunchai SP, Popaya W, Supawita T (2004b): Antibacterial activity of crude extracts of medicinal plants used in Thailand against pathogenic bacteria. Ethnopharmacologia 33: 60–65. [CSA]
- Voravuthikunchai SP, Brusentsev S, O'Rourke J, Mitchell H (2004c): Efficacy of crude extracts of Thai medicinal plants on antibiotic-resistant Helicobacter pylori. strains isolated from peptic ulcers. Clin Microbiol Infect 10(Suppl 1): 334. [CSA]
- Yoh M, Frimpong EK, Voravuthikunchai S, Honda T (1999): Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production and release of Vero toxin by enterohaemorrhagic Escherichia coli. O157:H7. Can J Microbiol 45: 732–739. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]